NASDAQ: ALNY · Biotechnology
Over the past week, Alnylam Pharmaceuticals (ALNY) racked up 17 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 11% bullish but is far apart: X runs 33% bullish while News sits at just 0%. Wall Street is more constructive, with 22 of 28 analysts rating ALNY a buy.
There is little buzz around ALNY this week and some agreement on direction, which is why it reads as a Sell.
Wall Street’s 79% buy share sits next to a crowd that ranges from News at 0% to X at 33%. No other tracker puts the two side by side.
Across 28 analysts the consensus is a Strong Buy: 22 buy calls against 0 sell, with an average 12-month price target of $375.76.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 68 points above the crowd average of 11%, the professionals are more constructive than retail. The split is inside the crowd: X reads 33% bullish while News sits at 0%, a 33-point spread that single-source trackers miss.
Over the 30-day window, Alnylam Pharmaceuticals (ALNY) buzz held subdued around 14.0 while the price drifted down 14.5% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 2.2M shares. Updated Aug 15, 2026. Over the last 7 trading days, ALNY gained 5.8%. Buzz activity in the recent week averaged 24.0 and was variable, swinging between 13.5 and 51.6. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 8 of the 18 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for ALNY and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ALNY sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (22 / 6 / 0) |
| Crowd bullish (7d) | 11% |
| Avg price target | $375.76 |
| Most bullish source | X, 33% |
| Most bearish source | News, 0% |
| Sentiment spread | 33 pts |
| Mentions (7d) | 17 |
| Market cap | $30.6B |
| P/E · Forward P/E | 39.6 · 25.0 |
| EPS · Beta | $5.78 · 0.3 |
| Revenue (TTM) | $4.8B · 16% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Alnylam Pharmaceuticals (ALNY) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 11% bullish across 3 active sources. Those sources contribute 17 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Alnylam Pharmaceuticals (ALNY) is fairly quiet with 0 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Alnylam Pharmaceuticals (ALNY), averaging 11% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 33% bullish and News at 0%, a 33-point spread. On the professional side, 22 of 28 analysts rate ALNY a buy.
Of the 28 analysts covering Alnylam Pharmaceuticals (ALNY), 22 rate it a buy, 6 a hold and 0 a sell, for a strong buy consensus. The average price target is $375.76. That puts the street ahead of the crowd, which averages 11% bullish.
Alnylam Pharmaceuticals (ALNY)'s cross-source average is bearish at 11% bullish. All 3 tracked sources lean bearish. X reads 33% bullish, News reads 0% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Alnylam Pharmaceuticals (ALNY) at 11% bullish. All 3 tracked sources lean bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is rising across News. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 12 mentions (71% of total volume). News contributes 5 mentions. The cross-source average is bearish at 11% bullish, while news is the only source with rising 3-day activity. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ALNY's sell signal at 93/100 conviction reflects a bearish cross-source average at 11% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The ALNY sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key